Hans Lofgren

Journal article

Drug promotion in Australia: policy contestation and the tightening of regulation

While consumers have long been assumed to be in need of protection from drug promotion, it is now accepted that marketing to medical professionals should also be more closely controlled. Public health advocates have effectively highlighted the negative impact of promotion on quality use of...

The 'neglected diseases' dilemma?

Miniscule research resources are allocated to researching the diseases of developing countries such as malaria and the strains of HIV prevalent in Africa. Plainly, the commercial model of drug research fails to respond to the needs of the poor. But pressures are mounting on governments...